Clinical Library

 

Darren Wheeler, MD, Regional Medical Director of Anatomic Pathology, West Region at Quest... Show more
Darren Wheeler, MD, Regional Medical Director of Anatomic Pathology, West Region at Quest Diagnostics and AmeriPath, authored this supplement focused on improvements in cervical cancer screening and current guidelines, and the clinical benefits of liquid-based cytology as a key advancement in cervical cancer screening. Read the supplement: Technology Matters: How the Pap Test Protects Your Patients
Download
Dr. R. Marshall Austin, Professor of Pathology at Magee-Womens Hospital of University of... Show more
Dr. R. Marshall Austin, Professor of Pathology at Magee-Womens Hospital of University of Pittsburgh Medical Center, authored this supplement focused on the importance of HPV testing for cervical cancer screening, the performance of the approved testing methods currently available, and the clinical significance of the different testing methods and technology. Read the supplement: Technology matters: The clinical utility of HPV mRNA testing compared to DNA testing
Download
A comprehensive overview of current guidelines and recommendations in Cervical Cancer Screening,... Show more
A comprehensive overview of current guidelines and recommendations in Cervical Cancer Screening, this provider toolkit includes information on the benefits of co-testing for Pap + HPV together. Additionally, the latest research and insights are provided to address common perceptions about co-testing. Click to open the PDF resource From Guidelines to Practice: New Insights in Cervical Cancer Screening.
Download
Dr. Juan Felix, Professor of Clinical Pathology and Obstetrics & Gynecology at Keck School... Show more
Dr. Juan Felix, Professor of Clinical Pathology and Obstetrics & Gynecology at Keck School of Medicine of USC, authored this supplement focused on outcome and economic data supporting co-testing. Read the supplement: Primary HPV Testing vs. Co-testing for Cervical Cancer Screening
Download
Clinical Summary of Walboomers JM et al 1999. Abstract: A recent report that 93 percent of... Show more
Clinical Summary of Walboomers JM et al 1999. Abstract: A recent report that 93 percent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for HPV serum antibodies and HPV DNA. Read the Hologic clinical summary document for: Walboomers JM et al 1999. Please visit PubMed for the full abstract.
Download
Clinical Summary of Khan MJ, Castle PE, Lorincz AT et al From April 1, 1989, to November 2,... Show more
Clinical Summary of Khan MJ, Castle PE, Lorincz AT et al From April 1, 1989, to November 2, 1990, a total of 20 810 women in the Kaiser Permanente health plan in Portland, OR, enrolled in a cohort study of HPV and cervical neoplasia. Women were tested for 13 oncogenic HPV types by Hybrid Capture 2 (HC2), and those women with a positive HC2 test were tested for HPV16 and 18. Enrollment Pap smear interpretation and HPV test results were linked to histologically confirmed CIN3 and cervical cancer (> or = CIN3) occurring during 10 years of cytologic follow-up. Cumulative incidence rates were calculated with 95% confidence intervals for each interval up to 122 months using Kaplan-Meier methods. Read the Hologic clinical summary for Khan MJ, Castle PE, Lorincz AT et al. Please visit PubMed for the full text article.  
Download
On Aug. 21, 2018, the U.S. Preventive Services Task Force (USPSTF) posted a final recommendation... Show more
On Aug. 21, 2018, the U.S. Preventive Services Task Force (USPSTF) posted a final recommendation statement and final evidence summary on screening for cervical cancer. Visit the USPSTF site to view the most recently published recommendations and evidence for Cervical Cancer Screening.
On September 14 and 15, 2012, ASCCP worked with 23 other national organizations on a revision... Show more
On September 14 and 15, 2012, ASCCP worked with 23 other national organizations on a revision of the 2006 guidelines for management of abnormal screening tests and CIN/AIS. As a result of this effort ASCCP published Updated Consensus Guidelines on the Management of Women with Abnormal Cervical Cancer Screening Tests and Cancer Precursors © 2013. For further information on the guidelines, where to find them and their available formats visit the ASCCP website.